Clinical Study to Investigate the Efficacy of Orally Administered SA001 in Patients With Primary Sjögren's Syndrome
Clinical trial NCT05269810 · COMPLETED
Trial details
- NCT number
- NCT05269810
- Sponsor
- Samjin Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-29
- Primary completion
- 2022-02-25
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.